Convatec, a leading medical products and technologies company focused on solutions for the management of chronic conditions, announces the launch of Cure Aqua™ in the United States and Canada.

Nearly 40% of patients who received treatment for cervical cancer were still being prescribed outpatient opioids for pain management six months later, according to recently published study findings.

Substance use can escalate from a casual weekend binge to a severe problem in just a few days. Here’s how technology is making a difference. While each story of substance use disorder, or SUD, is ...

Since President Donald Trump issued a July 2025 executive order aimed at "ending crime and disorder on America's streets," national attention has increasingly focused on involuntary treatment as a ...

A central challenge in the opioid crisis in the US has been the underuse of lifesaving treatment and harm reduction programs. Conventional explanations focus on limited access to care when services ...

Drug overdose deaths among adolescents are increasing in the United States. Residential treatment facilities are one treatment option for adolescents with substance use disorders, yet little is known ...

The effectiveness of different treatment options for opioid use disorder (OUD) will vary between people. Generally, the most effective option is a combination of medication and counseling. OUD ...

Namodenoson has received FDA approval for compassionate use in a U.S. pancreatic cancer patient, despite not being fully approved yet. The drug targets the A3 adenosine receptor, showing potential in ...

Treatment is key to addressing SUDs and reducing overdoses, deaths and other health or social complications. However, the rates at which Medicaid enrollees receive treatment can vary due to a wide ...